JAK1 and acute lymphoblastic leukemia: Our results are in line with the poor prognosis for patients with JAK1 mutations originally reported for adult T-ALL [53] and with the poor prognosis for patients with NRAS/KRAS mutations reported for adult T-ALL patients treated in the GRAALL-2003 and GRAALL-2005 trials [54].